Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Antonio C. Wolff,M. Elizabeth H. Hammond,Kimberly H. Allison,Brittany E. Harvey,Pamela B. Mangu,John M. S. Bartlett,Michael Bilous,Ian O. Ellis,Patrick L. Fitzgibbons,Wedad Hanna,Robert B. Jenkins,Michael F. Press,Patricia A. Spears,Gail H. Vance,Giuseppe Viale,Lisa M. McShane,Mitchell Dowsett

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

2018

Antonio C. Wolff
M. Elizabeth H. Hammond
Kimberly H. Allison
Brittany E. Harvey
Pamela B. Mangu
John M. S. Bartlett
Michael Bilous
Ian O. Ellis
Patrick L. Fitzgibbons
Wedad Hanna
Robert B. Jenkins
Michael F. Press
Patricia A. Spears
Gail H. Vance
Giuseppe Viale
Lisa M. McShane
Mitchell Dowsett

Purpose.— To update key recommendations of the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) human epidermal growth factor receptor 2 (HER2) testing in breast ...

Keywords:

Clinical Oncology
Clinical Practice
Guideline
Breast cancer
Human Epidermal Growth Factor Receptor 2
Oncology
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations